Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 01-2015 | 12-2014 | 10-2014 | 09-2014 | 07-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -13,350 | N/A | -8,645 | N/A |
| Depreciation Amortization | 430 | 430 | N/A | 37 | 20 |
| Accounts payable and accrued liabilities | N/A | 487 | N/A | 367 | N/A |
| Other Working Capital | 610 | 610 | N/A | 1,286 | 540 |
| Other Operating Activity | 1,050 | 573 | 0 | 39 | 390 |
| Operating Cash Flow | $2,090 | $-11,250 | $N/A | $-6,916 | $950 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -150 | -150 | N/A | -83 | -70 |
| Investing Cash Flow | $-150 | $-150 | $N/A | $-83 | $-70 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 2,208 | N/A | 2,208 | N/A |
| Debt Issued | N/A | 5,000 | N/A | -708 | N/A |
| Common Stock Issued | N/A | -972 | N/A | 228 | N/A |
| Other Financing Activity | 5,220 | -716 | 0 | 4,815 | 1,150 |
| Financing Cash Flow | $5,220 | $5,520 | $N/A | $6,543 | $1,150 |
| Beginning Cash Position | N/A | 9,780 | N/A | 9,781 | N/A |
| End Cash Position | N/A | 3,890 | N/A | 9,325 | N/A |
| Net Cash Flow | $7,160 | $-5,880 | $N/A | $-456 | $2,030 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,090 | -11,250 | N/A | -6,916 | 950 |
| Capital Expenditure | N/A | -159 | N/A | -83 | N/A |
| Free Cash Flow | 2,090 | -11,409 | 0 | -6,999 | 950 |